A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.


The study serves as a confirmation of safety, tolerance and efficacy of PICOPREP in clinical practice.

Full Title of Study: “Compliance and Efficacy in the Use of PICOPREP for Bowel Cleansing”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 2011


  • Drug: sodium picosulphate
    • Sodium picosulphate (PICOPREP®) taken by participant prior to X-ray examination, endoscopy or surgery.

Arms, Groups and Cohorts


Clinical Trial Outcome Measures

Primary Measures

  • Documentation of use PICOPREP in everyday practice
    • Time Frame: Day 0 – 2

Secondary Measures

  • Participant satisfaction and compliance after bowel cleansing
    • Time Frame: Days 0-2
  • Participants with adverse events reported by frequency and severity
    • Time Frame: Days 1-2

Participating in This Clinical Trial

Inclusion Criteria

  • Patients receiving PICOPREP® for bowel evacuation prior to endoscopy or surgery Exclusion Criteria:

  • Patients in which prescription of PICOPREP® is contraindicated

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ferring Pharmaceuticals
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Clinical Development Support, Study Director, Ferring Pharmaceuticals

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.